Bioethics News

Financial Ties Between Researchers and Drug Industry Linked to Positive Trial Results

January 18, 2017

(Medical Xpress) – Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ today. Relationships with industry are common among investigators of randomised clinical trials (RCTs) – raising concerns about the effect that financial ties may have on the evidence base. But studies investigating these relationships have been conflicting. So a team of US based researchers set out to investigate the association between financial ties of principal investigators and study outcomes in a random sample of 195 drug trials published in 2013.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.